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Abstract In hamsters fed high fat diets enriched in trimyristin, 
tripalmitin or tristearin, increased dietary cholesterol content 
was associated with increased plasma concentrations of very low 
density lipoprotein (VLDL) cholesterol and triacylglycerol 
(p < 0.0001 and p = 0.0017, respectively). Hepatic microsomal 
triglyceride transfer protein (MTP) mRNA concentration also 
increased (p < 0.0001), independent of the nature of dietary fat, 
and was significantly correlated with the plasma VLDL lipid 
concentrations (p = 0.0002 and p = 0.0106 for cholesterol and 
triacylglycerol, respectively) and hepatic cholesterol concentra- 
tions. Increased expression of the MTP gene may be part of a 
coordinated response to hepatic cholesterol accumulation leading 
to increased VLDL lipid secretion. 
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1. Introduction 
The microsomal triglyceride transfer protein (MTP) is a 
heterodimeric protein thought to play an essential role in 
the synthesis of apoB-containing lipoproteins: chylomicrons 
in the intestine and very low density lipoprotein (VLDL) in 
the liver. The larger of its two subunits catalyses the transfer 
of triacylglycerols (TAGs), cholesteryl esters and phospholip- 
ids between phospholipid surfaces [1] and in enterocytes and 
hepatocytes has been postulated to ferry TAGs from their site 
of synthesis on the smooth endoplasmic reticulum to the site 
of VLDL assembly. Support for a critical role for the protein 
in vivo is provided by patients with abetalipoproteinaemia. 
Such patients lack functional MTP, due to defects in the 
MTP gene and are unable to assemble or secrete chylomicrons 
and VLDL [2]. The human and hamster MTP genes have 
been cloned and the promoter sequences hown to contain a 
negative insulin response lement and modified sterol response 
element [3]. Transient ransfection analysis of MTP promoter- 
driven luciferase gene expression in HepG2 cells indicated that 
insulin down regulates and cholesterol up regulates MTP pro- 
moter activity. More recent studies on HepG2 cells confirmed 
the negative regulation of MTP gene expression by insulin [4]. 
Studies in vivo in the hamster have implied that dietary fac- 
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tors may affect hepatic MTP mRNA concentrations. The 
feeding of high fat [5,6] or high sucrose [5] diets caused an 
increase in hepatic mRNA concentrations that correlated with 
increased plasma cholesterol and the cholesterol content of 
individual ipoprotein fractions. Interestingly, in these experi- 
ments [5,6], there were no significant correlations between 
hepatic MTP mRNA levels and either plasma total or 
VLDL TAG. Furthermore, in diabetic and suckling rats, 
both conditions in which there is a reduced output of 
VLDL, no decrease in hepatic MTP activity or protein was 
seen [7]. 
In hamsters fed modest amounts of cholesterol, VLDL chol 
and TAG concentrations were significantly increased and 
these increases were associated with increased activity of phos- 
phatidate phosphohydrolase-1 (PAP-I), an enzyme thought to 
be important in regulating TAG synthesis [8]. There have been 
no reports to date of in vivo effects of dietary cholesterol 
upon MTP gene expression. In the present study we investi- 
gated the effects of diets enriched in both fat and increasing 
amounts of cholesterol on the concentrations of plasma 
VLDL chol and TAG and concentrations of hepatic MTP 
mRNA.  
2. Materials and methods 
2.1. Animals and diets 
60 male DSNI Golden Syrian hamsters were obtained from a closed 
colony in the Biomedical Services Unit, University of Nottingham. 
They were housed individually, under environmentally controlled con- 
ditions and allowed free access to food and tap water. After a 2 week 
acclimatization period they were transferred for a further 2 weeks to a 
standard control diet containing: 235 g/kg casein, 106 g/kg sucrose, 
503 g/kg cornstarch, 35 g/kg cellulose, 50 gJkg triolein and 5 g/kg 
linseed oil. The diet was also supplemented with standard rodent 
vitamin and mineral mixes (ICN Flow, Bucks., UK). Initially this 
diet was mixed with normal rodent chow at a ratio of 25:75 (Special 
Diet Supplies, Essex, UK) with the proportion of chow being de- 
creased to 50% and finally to 20%. Animals were then allocated at 
random to groups of 6 (TM and TP diets) or 8 (TS diets) and were 
transferred to a high fat diet (20°/,, w/w) containing 0.005'70 (diet A), 
0.12% (diet B) or 0.24% (diet C) cholesterol. These high fat diets were 
isocaloric to the control diet and contained the same proportions of 
protein, sucrose, linseed oil, vitamin and minerals. The fat consisted 
of 100 g/kg triolein (TO, Fluka, Derbys., UK) and a further 100 g of 
either trimyristin (TM, Fluka), tripalmitin (TP, Fluka) or tristearin 
(TS, Sigma Chemical Co., Dorset, UK). Energy content was main- 
tained by reducing starch to 156 g/kg and increasing cellulose to 232 
g/kg. Diets were again fed in combination with 20% chow to enhance 
palatability. Thus, animals were fed one of 3 different types of high fat 
diets enriched in TO and a saturated fat. In each case, cholesterol was 
included at one of 3 different levels, giving a total of 9 different diets. 
Animals were fed these diets for 28 days with food being completely 
replaced, every 2 days. On day 28 of the study period, the animals 
were fasted overnight prior to exsanguination the next day. Animals 
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were anaesthetized with Sagatal and blood was collected by cardiac 
puncture. The liver was flushed with saline, divided into two portions, 
snap frozen and maintained at -40°C until required. 
2.2. Separation of lipoproteins 
VLDL, low density lipoprotein (LDL) and high density lipoprotein 
(HDL) were separated by preparative ultracentrifugation at density 
ranges of <: 1.006, 1.02 1.06 g/ml and > 1.06 g/ml, respectively, as 
previously described [9,10]. Cholesterol and triacylglycerol concentra- 
tions were determined automatically using the Olympus system re- 
agent 5000 cholesterol and GPO Trinder triacylglycerol kits, respec- 
tively. 
2.3. Determination of hepatic j~'ee and esterified cholesterol 
Hepatic free and esterified cholesterol were extracted, separated by 
thin-layer chromatography and assayed as previously described [9] 
2.4. Isolation of hepatic" total RNA and determination of MTP and 
apoB mRNA concentrations 
Total hepatic RNA was isolated by the guanidinium thiocyanate 
method essentially according to Chomczynski and Sacchi [11]. The 
mRNA concentrations for hepatic MTP and apoB genes were deter- 
mined by a solution hybridization/RNAse protection assay as de- 
scribed previously [6,9]. Results were corrected for variation in the 
mRNA content of total RNA samples by quantitation of poly(A) 
RNA using oligo-dTls hybridization [12]. All mRNA values are ex- 
pressed as amol mRNA/~tg total RNA. 
2.5. Statistical analysis 
MTP mRNA concentration data were analyzed by two-way analy- 
sis of variance (ANOVA) using Genstat-5 statistical software (Lawes 
Agricultural Trust, Rothamsted, Herts.). If this produced a p < 0.05 
groups were compared using the Tukey-Kramer multiple comparisons 
test. Linear regression was performed using C-Stat for Windows soft- 
ware (Cherwell Scientific Publishing Ltd., Oxford, UK). 
3. Results and discussion 
Diets were well tolerated by all but six animals (one in each 
TM group, one each in TP groups B and C, and one in TS 
group B) which were removed from the trial, having lost more 
than 10% of their initial body weight. No significant differ- 
ences between the various groups were seen in starting or final 
body weight or food intake in the remaining animals. 
When animals were fed increasing amounts of cholesterol as 
part of a diet enriched in 3 different saturated fats, the con- 
centration of hepatic MTP mRNA increased (Table 1). Anal-  
ysis of these data by two-way ANOVA indicated that the 
concentrat ion of MTP mRNA is not significantly affected 
by the nature of the fat, with no significant interaction be- 
tween type of fat and amount  of dietary cholesterol. This is in 
contrast o our recent work on hepatic apoB, LDL receptor 
and hydroxymethylglutaryl-CoA reductase mRNA levels 
which appear to be differentially regulated by different satu- 
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Fig. 1. Correlation of VLDL cholesterol (A) and VLDL triacylglyc- 
erol (B) concentrations with hepatic MTP mRNA concentrations. 
Hamsters were fed high fat (TM, TP or TS) diets containing 0.005, 
0.12 or 0.24% cholesterol for 28 days. After an overnight fast, blood 
was collected and the liver removed. Plasma VLDL was isolated by 
preparative ultracentrifugation a d cholesterol and triacylglycerol 
concentrations determined as indicated in Section 2. Hepatic mRNA 
concentrations for the MTP gene were determined by nuclease pro- 
tection assay as described in Section 2. Linear correlation coeffi- 
cients were: (A) r = 0.4943, p = 0.0002; (B) r = 0.3515, p = 0.0106. 
rated fats ([9]; unpublished observations). Thus, MTP  mRNA 
concentration is primarily dependent on the amount  of chol- 
esterol in the diet. Indeed, a highly significant correlation 
between MTP mRNA and dietary cholesterol was evident 
(Table 2, p<0.0001) .  Both VLDL TAG and cholesterol 
were also markedly increased in response to dietary cholester- 
ol, each showing strong linear correlations (Table 2, p = 0.0017 
and p < 0.0001, respectively) and were also highly correlated 
with each other (Table 3, p<0.0001) ,  consistent with in- 
creased VLDL secretion. This confirms our previous findings 
with a separate strain of Golden Syrian hamster which exhib- 
ited an even greater triacylglycerol response to dietary choles- 
Table 1 
Hepatic MTP mRNA concentrations in hamsters fed different saturated fats and different amounts of cholesterol 
Diet Dietary chol TM TP TS All fats 
(w/w %) 
(A) 0.005 3.14 -+ 0.389 2.81 + 0.302 2.88 + 0.478 2.93 + 0.403 
n=5 n=6 n=7 n=18 
(B) 0.12 3.54 + 0.393 3.07 -+ 0.343 3.60 + 0,575 3.45 + 0.513 
n=4 n=4 n=8 n=16 
(C) 0.24 3.86 + 0.245 3.83 -+ 0.557 3.73 + 0,658 3.79 + 0.519 
n=5 n=5 n=8 n= 18 A b, B ~ 
Values are in atomoles/~tg RNA and represent mean + standard eviation with the number of animals indicated. Data were analysed by 2-way 
analysis of variance with dietary fat and cholesterol as the variables. No significant effect of the type of fat and no significant interaction between 
type of fat and amount of dietary cholesterol were observed. Thus, data from each fat were pooled to give an overall effect of cholesterol. 
Significant differences between cholesterol concentrations are indicated: ~p < 0.05; bp < 0.001. 
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Table 2 
Linear correlation coefficients for relationships with dietary choles- 
terol 
Parameter r value p value 
VLDL chol 0.6904 < 0.0001 
VLDL TAG 0.4171 0.0017 
MTP mRNA 0.6079 < 0.0001 
apoB mRNA 0.1842 0.2003 
Hamsters were fed and analyses performed as described in Table 1 
and Section 2. Data from all animals were pooled. 
terol. In this previous trial we showed that cholesterol feeding 
was associated with an increase in the activity of PAP-l, a 
rate-limiting enzyme in TAG synthesis [8]. In the present 
study, while the concentrations of both lipid components of 
VLDL increased, the rise was greater for cholesterol and re- 
sulted in a fall in the VLDL TAG/chol ratio to produce a 
potentially more atherogenic particle (data not shown). There 
was a dramatic increase in hepatic cholesteryl ester with in- 
creasing dietary cholesterol and also a smaller, but highly 
significant, increase in free cholesterol, with significant linear 
correlations with dietary cholesterol (p < 0.001 and p < 0.002, 
respectively) for all three saturated fat diets. Furthermore, 
plasma VLDL cholesterol concentrations were strongly corre- 
lated with hepatic cholesterol ester concentrations (Table 3, 
p < 0.0001). These correlations support he suggestion that the 
increase in VLDL output from the liver may be an attempt to 
mobilize increasing hepatic holesterol stores [8,13]. 
The hepatic TAG produced by increased PAP-1 activity has 
to be incorporated, together with apoB and cholesteryl ester 
into the VLDL particles. Both MTP activity and apoB are 
required for this process. However, there was no consistent 
increase in hepatic apoB mRNA concentrations oncholesterol 
feeding (Table 2) and no correlation with the plasma concen- 
trations of either VLDL chol or TAG, suggesting that, at least 
in this situation, apoB mRNA levels are not rate limiting for 
VLDL synthesis and secretion. By contrast, not only were 
MTP mRNA concentrations increased (Table 1), but they 
also strongly correlated with VLDL chol and TAG concen- 
trations (r = 0.4943, p < 0.0002 and r = 0.3515, p < 0.0106, re- 
spectively; Fig. 1). In contrast, no correlations were seen be- 
tween MTP mRNA and apoB mRNA, or low density 
lipoprotein (LDL) chol, whereas a significant positive correla- 
tion was observed between MTP mRNA and high density 
lipoprotein (HDL) chol (Table 3). It is noteworthy that we 
also found stronger correlations for hepatic MTP mRNA 
concentrations with HDL chol than LDL chol, when hamsters 
were fed increasing dietary fat at low cholesterol concentra- 
tions [6]. It remains to be established that the increases in 
MTP mRNA concentration bserved here result in increased 
protein levels and transfer activity. It is possible that increased 
amounts of MTP are required to transfer the increased 
amount of lipid to the maturing lipoprotein particle. Func- 
tional MTP appears to be required for VLDL production [2], 
facilitating both translocation of apoB across the endoplasmic 
reticulum and its association with lipid [14-16] and MTP ap- 
pears to be rate limiting for these processes in cultured cells 
[17,18]. However, reduced VLDL output in vivo does not 
appear to be associated with reduced MTP activity [7]. 
Thus, MTP activity may be only one of a number of factors 
involved in regulating VLDL synthesis and secretion [19]. 
It appears likely that the increased VLDL lipid output is in 
response to the increased accumulation of cholesteryl ester in 
the liver. There is conflicting evidence in the literature on the 
effects of increased hepatic holesteryl ester concentration  
the secretion of VLDL. Wu et al. [20] showed that a variety of 
manipulations which altered cholesteryl ester concentration in 
HepG2 cells had no effect on VLDL secretion, while Fungwe 
et al. [13,21] have described a stimulation of VLDL formation 
in the livers of rats and hamsters fed cholesterol-enriched 
diets. Recent data from human subjects also emphasise the 
importance of available cholesterol in regulating VLDL secre- 
tion [22]. The current data, together with our previous results 
[8], support he findings of Fungwe et al. [13,21]. It could be 
speculated that the need to mobilize increased amounts of 
cholesteryl ester elicits a coordinated response in the liver, 
whereby TAG synthesis, via PAP-l, MTP mRNA concentra- 
tions and incorporation of chol and TAG into VLDL are all 
up regulated. The strong positive correlations between MTP 
mRNA and hepatic free and esterified cholesterol concentra- 
tions (Table 3, p=0.0017 and p<0.0001, respectively), and 
between VLDL chol and hepatic cholesterol ester (Table 3, 
p<0.0001) support this notion. Approx. 50% of hamster 
VLDL chol is esterified (Salter, unpublished observations). 
It is entirely possible that MTP is involved in the transport 
of cholesteryl ester as well as triacylglycerol [23]. Interestingly, 
in the hamster, hepatic MTP mRNA concentrations tend to 
correlate better with lipoprotein cholesterol than with triacyl- 
glycerol concentrations ([5,6] and this work). 
The promoter egion of the MTP gene contains a modified 
sterol regulatory element and the expression of the gene may 
be up regulated by cholesterol [3]. However, addition of chol- 
esterol to HepG2 cells had only a minimal effect on MTP 
gene expression and the authors uggest that this is probably 
due to the inability of their Northern blot assay system to 
detect any moderate increase in MTP mRNA [3]. The increase 
in MTP mRNA resulting from increased ietary cholesterol in 
the present study may be a direct result of increased transcrip- 
tion mediated by the modified sterol regulatory element in the 
MTP promoter. Such speculation is supported by (i) the fact 
that expression of the 7a-hydroxylase g ne, which contains a
similar modified sterol regulatory element in its promoter, is 
also moderately regulated by cholesterol [24] and (ii) the pos- 
itive correlation of both hepatic free and esterified cholesterol 
concentrations with MTP mRNA concentrations (Table 3). 
Although an effect on mRNA stability cannot be ruled out 
at this stage, previous studies have demonstrated that in- 
creases in MTP mRNA concentrations are due to transcrip- 
tional activation [3]. 
To our knowledge these results represent the first demon- 
Table 3 
Linear correlation coefficients for relationships of hepatic MTP 
mRNA and lipoprotein or hepatic lipid concentrations 
Parameter A Parameter B r value p value 
MTP mRNA LDL chol 0.1166 0.4103 
MTP mRNA HDL chol 0.3828 0.0051 
MTP mRNA apoB mRNA 0.1508 0.2958 
MTP mRNA hep chol 0.4245 0.0017 
MTP mRNA hep chol ester 0.5220 < 0.0001 
VLDL chol hep chol ester 0 .5333 <0.0001 
VLDL chol VLDL TAG 0.6615 < 0.0001 
Hamsters were fed and analyses performed as described in Table 1 
and Section 2. Data from all animals were pooled. Hep chol and hep 
chol ester efer to hepatic free and esterified cholesterol, respectively. 
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stration of an increase in MTP mRNA in vivo in response to 
dietary cholesterol and differs from the high fat diet effects 
which have been ascribed to the induction of hepatic insulin 
insensitivity alleviating the down regulation of MTP gene ex- 
pression via the insulin response lement [4]. 
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